8-K: LifeMD Reschedules Q3 Earnings, Cites Accounting Corrections

LifeMD, Inc. has rescheduled its third quarter 2025 earnings release and conference call to November 17, 2025, due to identified accounting corrections impacting prior period revenue recognition.

Summary

• LifeMD, Inc. has rescheduled its third quarter 2025 earnings release and conference call from November 5, 2025, to Monday, November 17, 2025.
• The company expects to file a Form 12b-25, notifying the U.S. Securities and Exchange Commission of a late filing of its Form 10-Q for the period ended September 30, 2025.
• The change in the earnings release date relates to corrections identified following data system migrations concerning revenue recognition with offsetting related balance sheet accounts.
• These corrections impact the twelve months ended December 31, 2023, December 31, 2024, and the six months ended June 30, 2025.
• The cumulative impact of these changes will be approximately $4.6 million, representing about 1.4% of cumulative revenue reported during that period.
• The company assesses that these required adjustments will not materially impact how reported revenue results compared to guidance for the affected reporting periods.
• The required adjustments will not impact the company's cash flow or cash position.

Sentiment

Score: 3

Explanation: The delay in earnings and the need for accounting corrections, even if deemed non-material to guidance or cash flow, typically signal operational or internal control weaknesses. While the financial impact is stated as small relative to cumulative revenue, the underlying issue of errors and potential internal control impact is a negative signal. The proactive disclosure and stated non-material impact on cash flow are mitigating factors, but the overall sentiment is cautious due to the delay and accounting issues.

Positives

• The required adjustments will not materially impact how reported revenue results compared to guidance for the reporting periods during this timeframe.
• The required adjustments will not impact the company's cash flow or cash position.

Negatives

• The third quarter 2025 earnings release and conference call have been rescheduled.
• The company expects to file a Form 12b-25 for a late filing of its Form 10-Q for the period ended September 30, 2025.
• Corrections were identified related to the recognition of revenue with offsetting related balance sheet accounts.
• The cumulative impact of these changes is approximately $4.6 million in revenue adjustments.
• The company is evaluating the potential impact of these matters on internal control over financial reporting.

Risks

• The preliminary determinations regarding accounting adjustments are subject to further adjustment as the company prepares its financial statements and disclosures for the three and nine months ended September 30, 2025, and such adjustments may be significant.
• The company's auditors have not audited, reviewed, compiled, or applied agreed-upon procedures with respect to the preliminary determinations described.
• Factors that could materially affect forward-looking statements include the completion of the review of the accounting matters identified, including the potential impact on internal control over financial reporting.
• Forward-looking statements are subject to inherent risk, uncertainties, and changes in circumstances and assumptions that are difficult to predict, including some of which are out of the company's control.
• Actual results, performance, and financial condition may differ materially from those indicated in the forward-looking statements.

Future Outlook

The company expects to issue its third quarter 2025 earnings press release and hold its conference call on November 17, 2025. Preliminary determinations regarding accounting adjustments are subject to change and may be significant, and the company is evaluating the potential impact on internal control over financial reporting.

Management Comments

• We expect to file a Form 12b-25 as needed, notifying the U.S. Securities and Exchange Commission of a late filing of our Form 10-Q for the period ended September 30, 2025.
• Based on our assessment, these required adjustments will not materially impact how reported revenue results compared to guidance for the reporting periods during this timeframe.
• Required adjustments will not impact our cash flow or cash position.

Industry Context

This filing primarily concerns internal accounting issues and a delayed earnings report for LifeMD, a provider of virtual healthcare services and pharmacy. It does not directly address broader industry trends or competitive landscape shifts.

Stakeholder Impact

• Shareholders may experience uncertainty due to delayed financial reporting and accounting corrections, potentially impacting stock price volatility. The stated non-material impact on guidance and cash flow aims to reassure.
• Investors and analysts will need to adjust their schedules for the earnings call and will scrutinize the details of the accounting corrections and their implications for future reporting and internal controls.

Next Steps

• LifeMD expects to issue its third quarter 2025 earnings press release on or around 4:05 p.m. Eastern time on Monday, November 17, 2025.
• A conference call will follow at 4:30 p.m. Eastern time on November 17, 2025.
• The company expects to file a Form 12b-25 as needed for the late Form 10-Q.
• The company will complete the review of the accounting matters identified, including the potential impact on internal control over financial reporting.

Key Dates

Recommendation

The delay in earnings and the need for accounting corrections, even if the financial impact is stated as non-material to guidance or cash flow, introduce uncertainty and raise questions about internal controls. While the company has provided some reassurance regarding the impact, investors will likely adopt a 'wait and see' approach until the full Q3 results are released and the accounting issues are fully resolved and explained. The potential impact on internal control over financial reporting is a significant concern that warrants caution.

Keywords

LifeMD, LFMD, LFMDP, earnings release, conference call, Form 10-Q, late filing, SEC, accounting corrections, revenue recognition, financial statements, virtual healthcare, telemedicine, Q3 2025